10 July 2008 12:45 [Source: ICIS news]
Dow will pay $78/share for the Philadelphia-based company and contribute its coatings, biocides and personal care operations to the deal to create a $13bn (€8.3bn) turnover business.
The transaction marks a decisive move in Dow’s transformation into an earnings growth company with reduced cyclicality, the chemical giant said in a statement.
“After an extensive analysis of acquisition opportunities in the marketplace, it became clear that Rohm and Haas is the ideal company to accelerate Dow’s transformation,” Dow chief executive Andrew Liveris said.
“The addition of Rohm and Haas’ portfolio is game-changing for Dow, enabling us to accelerate Dow’s transformation,” he added.
Dow has yet to finalise a joint venture with the Petrochemicals Industries Company (PIC) of ?xml:namespace>
But with the collective impact of these two deals, performance productions and advanced materials will account for 69% of Dow’s total sales on a 2007 pro forma basis compared with 51% before, Dow said.
Dow shares were trading at €21 on Europe's Xetra exchange, down €1.07 or 4.85% on the previous close.
To discuss issues facing the chemical industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|